Dr. Busui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-3273Fax+1 503-418-2208
Education & Training
- University of MichiganFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2001
- University of Medicine and Pharmacy TimisoaraClass of 1987
Certifications & Licensure
- MI State Medical License 1997 - 2026
- OR State Medical License 2024 - 2025
- OH State Medical License 2001 - 2023
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Research Affairs Core Committee Member Endocrine Society, 2020
- Chair, Diabetes and Cardiovascular Complications Interest Group American Diabetes Association, 2018-2020
- Chair, Clinical Research Review American Diabetes Association, 2017-2020
- Join now to see all
Clinical Trials
- Adjunct Collection of Additional Biorepository Data From Patients Enrolled in Diabetic Foot Consortium (DFC) Trials Start of enrollment: 2021 May 01
Roles: Principal Investigator
Publications & Presentations
PubMed
- 4 citationsCardiovascular Autonomic Neuropathy and Risk of Kidney Function Decline in Type 1 and Type 2 Diabetes: Findings From the PERL and ACCORD Cohorts.Yaling Tang, Lynn Ang, Mamta Jaiswal, Brendan R Dillon, Nazanene H Esfandiari
Diabetes. 2024-05-01 - 50 citationsEffects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney...Darren K McGuire, Rodica P Busui, John Deanfield, Silvio E Inzucchi, Johannes F E Mann
Diabetes, Obesity & Metabolism. 2023-07-01 - 109 citationsSafety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.Anders L. Carlson, Jennifer L. Sherr, Dorothy I. Shulman, Satish K. Garg, Rodica Pop-Busui
Diabetes Technology & Therapeutics. 2021-11-16
Press Mentions
- NSAIDs Linked to Heart Failure Risk in DiabetesAugust 25th, 2022
- Eat Better, Move, but Don’t Worry About DiabetesJune 25th, 2022
- Adjunct Collection of Additional Biorepository Data from Patients Enrolled in Diabetic Foot Consortium (DFC) TrialsOctober 25th, 2021
- Join now to see all
Grant Support
- PERL A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1DNIDDK2013–2018
- Adjunctive versus Replacement Continuous Glucose Monitoring (CGM) RCTHelmsley Trust Foundation2015–2016
- Impact of glycemic variability on cardiovascular autonomic neuropathy and cardiomyopathy in type 1 diabetesAmerican Diabetes Association2014–2016
- Tissue-Specific Metabolic Reprogramming in Diabetic ComplicationsNIDDK2011–2016
- Cardiac Autonomic Neuropathy and Myocardial Dysfunction in Type 1 Diabetes.National Heart Lung Blood Institute2010–2016
Committees
- member, Standards of Medical Care in Diabetes - 2015
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: